ReposiTrak, Inc.
TRAKReposiTrak, Inc. (TRAK) is a provider of supply chain management and compliance solutions for the food, beverage, dietary supplement, and pharmaceutical industries. The company offers a cloud-based platform that enables businesses to enhance traceability, manage recalls, and ensure regulatory compliance across their supply chains. ReposiTrak aims to improve efficiency, safety, and transparency in complex product distribution networks.
Dividend History
Investors can expect a dividend payout of $0.02 per share, scheduled to be distributed in 27 days on August 14, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 14, 2026 | $0.02 | 2026-06-30 | 2026-06-30 |
| May 15, 2026 | $0.02 | 2026-03-31 | 2026-03-31 |
| February 13, 2026 | $0.02 | 2025-12-31 | 2025-12-31 |
| November 14, 2025 | $0.02 | 2025-09-30 | 2025-09-30 |
| August 14, 2025 | $0.02 | 2025-06-30 | 2025-06-30 |
Dividends Summary
- Consistent Payer: ReposiTrak, Inc. has rewarded shareholders with 11 dividend payments over the past 2 years.
- Total Returned Value: Investors who held TRAK shares during this period received a total of $0.20 per share in dividend income.
- Latest Payout: The most recent dividend of $0.02/share was paid 64 days ago, on May 15, 2026.
- Yield & Schedule: TRAK currently pays dividends quarterly with an annual yield of 0.91%.
- Dividend Growth: Since 2024, the dividend payout has grown by 21.2%, from $0.02 to $0.02.
- Dividend Reliability: TRAK has maintained or increased its dividend for 11 consecutive payments.
Company News
ReposiTrak is set to release quarterly earnings on September 29, 2025, with analysts estimating an EPS of $0.09. The company previously beat EPS estimates by $0.10, but experienced a stock price drop afterward.
TRAK, the Park City Group, has reached an all-time high of $18.84, reflecting the company's strong performance and positive market sentiment. The company's subsidiary, ReposiTrak, also reported solid growth in its fiscal third quarter, with plans to double its revenue in the next two years.
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday. Shares of Aehr Test Systems (NASDAQ: AEHR) fell sharply during Monday’s session after the company reported preliminary third-quarter and FY24 adjusted EPS and revenue results below estimates. Aehr reported preliminary third-quarter revenue of $7.6 million and...
